Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Enterprise Value (2020 - 2025)

Historic Enterprise Value for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$57.2 million.

  • Maravai Lifesciences Holdings' Enterprise Value rose 8158.31% to -$57.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$57.2 million, marking a year-over-year increase of 8158.31%. This contributed to the annual value of -$71.9 million for FY2024, which is 6439.74% up from last year.
  • According to the latest figures from Q3 2025, Maravai Lifesciences Holdings' Enterprise Value is -$57.2 million, which was up 8158.31% from -$67.8 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Enterprise Value high stood at $379.1 million for Q1 2023, and its period low was -$310.4 million during Q3 2024.
  • Its 5-year average for Enterprise Value is $2.1 million, with a median of -$57.2 million in 2025.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Enterprise Value soared by 24704.01% in 2021 and then crashed by 21838.1% in 2022.
  • Over the past 5 years, Maravai Lifesciences Holdings' Enterprise Value (Quarter) stood at $229.9 million in 2021, then crashed by 218.38% to -$272.1 million in 2022, then increased by 25.83% to -$201.8 million in 2023, then surged by 64.4% to -$71.9 million in 2024, then rose by 20.46% to -$57.2 million in 2025.
  • Its Enterprise Value stands at -$57.2 million for Q3 2025, versus -$67.8 million for Q2 2025 and -$55.4 million for Q1 2025.